Long-term survival in 463 women treated with platinum analogs for advanced epithelial carcinoma of the ovary: life expectancy compared to women of an age-matched normal population
Authors:
- 1 September 2004
- journal article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 14 (5) , 772-778
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Trends in United States ovarian cancer mortality, 1979–1995Obstetrics & Gynecology, 1999
- Ten-year follow-up of ovarian cancer patients after second-look laparotomy with negative findingsObstetrics & Gynecology, 1999
- Prognosis of 2,800 patients with epithelial ovarian cancer diagnosed during 1975‐94 and treated at the Norwegian Radium HospitalActa Obstetricia et Gynecologica Scandinavica, 1998
- Prognostic factors in advanced ovarian cancerInternational Journal of Gynecological Cancer, 1997
- A randomized trial of five versus eight courses of cisplatin or carboplatin in advanced epithelial ovarian carcinomaAnnals of Oncology, 1997
- Twelve-year follow-up of a randomized trial comparing cisplatin and cyclophosphamide with cisplatin, doxorubicin and cyclophosphamide in patients with advanced epithelial ovarian cancerInternational Journal of Gynecological Cancer, 1996
- A randomized trial comparing single-agent carboplatin with carboplatin followed by radiotherapy for advanced ovarian cancer: a North Thames Ovary Group study.Journal of Clinical Oncology, 1993
- Adjusting survival curves for imbalances in prognostic factorsBritish Journal of Cancer, 1988
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958